US Patent 11787796 Plasma Kallikrein inhibitors and uses thereof
Patent 11787796 was granted and assigned to Takeda Pharmaceutical Company on October, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11787796 Plasma Kallikrein inhibitors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
